Stephan Jackman
Chief Executive Officer at Alzamend Neuro Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Alzamend Neuro Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Alzamend Neuro Inc. April 17, 202685.2%
-
Alzamend Neuro Inc. April 25, 202597.4%
-
Alzamend Neuro Inc. May 1, 202495.5%
-
Alzamend Neuro Inc. April 26, 202398.1%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Apr 28, 2023 | Alzamend Neuro Inc. | Open-market purchase | +37,000 | $0.54 | $19,980 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.